Spectrum Of Antimicrobial Susceptibility Pattern of Urinary Tract Infection in In Adults
Abstract
Patients of all ages and genders regularly experience urinary tract infections. Antibiotic misuse has caused organisms to develop drug resistance, creating a treatment problem. Objective: To uncover risk variables and relationships, as well as the antibiotic susceptibility in UTI patients. Methods: Diabetes and non-diabetes with UTI were compared within groups using the Chi-square test, with a significant P-value of 0.05. Results: 32 (21.2%) were given empirical treatment with ciprofloxacin (11%), cefixime (5%), ceftriaxone (2.6%), cefoparazone-sulbactum (1.30%), amoxicillin-clavulanic acid (1.30%), ampicillin (1.30%), and co-trimoxazole (0.60%), respectively. E. coli was the most prevalent pathogen, with an isolation rate of 84%, followed by pseudomonas aeruginosa (6%), Serratia (3.3%), klebsiella (2.6%), Enterobacter cloacae (2.6%), Sternotophomus (0.7%), and MRSA (each in 0.7%). Ampicillin, Cefixime, Ceftriaxone, Co-Trimoxazole, Ciprofloxacin, Amoxicillin-Clavulanic Acid, Tetracycline, and Levofloxacin were all often resistant to, respectively, 87 percent, 83 percent, 78 percent, 78 percent, and 51 percent of these antibiotics. Conclusions: MDR prevalence is highest in gram-negative bacteria. The presence of diabetes mellitus and being a woman are significant risk factors for UTI, according to tests. Escherichia coli (84%) is the most common uropathogen. Carbapenems, piperacillin-tazobactam, Amikacin, Gentamicin, and cefoparazone-sulbactam (parenteral) as well as…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.